The findings emphasize the importance of aniseikonia tests in clinical practice, which provide valuable insights into visual dysfunction and can aid in predicting treatment outcomes. Future efforts should prioritize the standardization of test parameters (luminance, contrast) and validation in diverse populations, particularly amblyopic and pediatric patients, to refine diagnostic thresholds. Emerging technologies such as tablets and cell phones will facilitate test administration and improve accessibility. Establishing consensus guidelines for clinical interpretation will enhance reliability in diagnosing and managing aniseikonia. By addressing these challenges, next-generation tests can better align theoretical accuracy with practical application, ultimately improving patient outcomes in conditions where binocular vision is compromised.
Tan et al. (Mon,) studied this question.